Side effects
Side effects as an overall problem
Side effects as an overall problem
Severity
Evaluations
Percentage
This item is relevant to you:
Severe
0
This item is relevant to you:
Moderate
0
This item is relevant to you:
Mild
1
This item is relevant to you:
None
7
Why patients stopped taking Tinted Lenses
Multiple reasons could be selected
Reason
Patients
Percentage
This item is relevant to you:
Did not seem to work
1
This item is relevant to you:
Expense
1
This item is relevant to you:
Other
1
This item is relevant to you:
Side effects too severe
1
See
all
2 patients
who've
stopped using Tinted Lenses
Duration
Stopped using Tinted Lenses
Duration
Patients
Percentage
This item is relevant to you:
1 - 2 years
1
This item is relevant to you:
10 years or more
1
Adherence
Adherence
Evaluations
Percentage
This item is relevant to you:
Always
6
6 evaluations from 6 patients
This item is relevant to you:
Usually
1
1 evaluation from 1 patient
This item is relevant to you:
Sometimes
1
1 evaluation from 1 patient
This item is relevant to you:
Never
taken as prescribed
0
0 evaluations from 0 patients
Burden
Burden
Evaluations
Percentage
This item is relevant to you:
Very
hard to take
0
0 evaluations from 0 patients
This item is relevant to you:
Somewhat
hard to take
1
1 evaluation from 1 patient
This item is relevant to you:
A little
hard to take
2
2 evaluations from 2 patients
This item is relevant to you:
Not at all
hard to take
5
5 evaluations from 5 patients
Cost per month
Cost per month
Evaluations
Percentage
This item is relevant to you:
$200+
0
0 evaluations from 0 patients
This item is relevant to you:
$100-199
0
0 evaluations from 0 patients
This item is relevant to you:
$50-99
0
0 evaluations from 0 patients
This item is relevant to you:
$25-49
0
0 evaluations from 0 patients
This item is relevant to you:
< $25
4
4 evaluations from 3 patients
This item is relevant to you:
Not specified
4
4 evaluations from 4 patients
What people switch to and from
Patients
started
using
Tinted Lenses
after stopping:
Treatment
Patients
Percentage
This item is relevant to you:
Erenumab
(Aimovig )
1
Last updated:
April 25, 2026